Olaplex (OLPX) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Q3 2024 net sales declined 3.6% year-over-year to $119.1 million, with sequential improvement from Q2 and international business underperforming; direct-to-consumer sales grew 6.8%, while professional and specialty retail channels declined.
Adjusted EBITDA was $44.6 million with a margin of 37.5%, down from 41.7% in Q3 2023; net income fell to $14.8 million from $20.4 million.
Gross profit margin improved to 68.6% from 67.6%, and adjusted gross profit margin rose to 70.8% from 69.7%, driven by lower product obsolescence write-offs.
The company is undergoing a transformation focused on long-term growth, innovation, operational improvements, and international expansion amid a challenging macroeconomic and competitive environment.
Leadership team strengthened with new COO/CFO, CMO, SVP International, and Interim Chief Accounting Officer; new product launches contributed to offsetting sales declines.
Financial highlights
Q3 2024 net sales: $119.1 million (down 3.6% year-over-year); U.S. sales down 3.3%, international down 3.9%.
Adjusted EBITDA: $44.6 million (down 13.4%); margin 37.5% (down from 41.7%).
Adjusted net income: $28.7 million ($0.04 per diluted share), down from $33.4 million ($0.05 per share) in Q3 2023; net income: $14.8 million.
Gross profit margin improved to 68.6% from 67.6%; adjusted gross profit margin rose to 70.8% from 69.7%.
Cash and cash equivalents at quarter-end were $538.8 million, up from $466.4 million at year-end 2023; inventory at $85.9 million, down $10 million since year-end.
Outlook and guidance
FY2024 net sales guidance lowered to $405–$415 million from $435–$463 million.
Adjusted EBITDA guidance reduced to $121–$127 million (margin 29.9%–30.6%), down from $143–$159 million (32.8%–34.3%).
Adjusted net income guidance cut to $67–$73 million (prior: $87–$100 million); adjusted gross margin expected at 70.9%–71.6%.
Full-year adjusted SG&A expected at $167–$170 million; non-payroll marketing spend at $62–$65 million.
Lowered outlook reflects weaker international performance, slower demand lift from new investments, and increased holiday promotions.
Latest events from Olaplex
- Q2 2024 net sales fell 4.8% but specialty retail grew; FY24 guidance and liquidity remain strong.OLPX
Q2 20248 Jul 2026 - 2024 sales and profit declined, but 2025 targets margin gains and innovation-led growth.OLPX
Q4 20248 Jul 2026 - Votes sought for director elections, executive pay, and auditor ratification at July 2026 meeting.OLPX
Proxy filing29 May 2026 - Director elections, say-on-pay, and auditor ratification headline a governance-focused annual meeting.OLPX
Proxy filing29 May 2026 - Net sales up 2.5% to $99.4M, but higher costs led to a net loss and a pending $1.4B merger.OLPX
Q1 202611 May 2026 - 2025 sales were flat, margins held, debt fell, and 2026 expects stable performance.OLPX
Q4 20255 Mar 2026 - Transformation strategy targets innovation, brand demand, and global growth for long-term success.OLPX
Raymond James & Associates’ 46th Annual Institutional Investors Conference 20253 Feb 2026 - 2025 strategy drives premium haircare growth, innovation, and global expansion with strong guidance.OLPX
Barclays 18th Annual Global Consumer Staples Conference 20253 Feb 2026 - Transformation focuses on innovation, pro engagement, and multi-channel growth amid strong demand.OLPX
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026